Latest Trials

Systemic therapy trial

Keynote-716 : Adjuvant Therapy With Pembrolizumab Versus Placebo in Resected High-risk Stage II...

This phase III trial is evaluating the safety and effectiveness of the immunotherapy drug, Pembrolizumab, in patients with surgically removed high-risk stage II melanoma

Status : Recruiting

Systemic therapy trial

GO30140 : An Open-Label, Multicenter Phase Ib Study of The Safety and Efficacy of Atezolizumab...

This phase I trial is evaluating the safety and effectiveness of two immunotherapy drugs (atezolizumab and bevacizumab) in combination with other treatments, including chemotherapy, for patients with select solid cancer types

Status : Recruiting

Systemic therapy trial

MK-4280-003 : A Phase 1/Phase 2 Clinical Study to Evaluate the Safety and Efficacy of a Combination of...

This phase I/II trial is evaluating an immunotherapy combination (MK-4280 and Pembrolizumab) in patients with Hodgkin Lymphoma, Non-Hodgkin Lymphoma or B-Cell Lymphoma

Status : Recruiting

Systemic therapy trial

M16-183 : Phase 1b Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory...

This phase I trial is evaluating two drugs (one oral and one intravenous) in Acute Myeloid Leukaemia (AML) patients who have gotten worse or not responded to treatment

Status : Recruiting

Systemic therapy trial

ALLG MM19 : A Phase 3 trial of thalidomide-dexamethasone consolidation versus...

This phase III trial is evaluating a chemotherapy-steroid combination as maintenance therapy for transplant-eligible multiple myeloma (MM) patients who are undergoing single autologous stem cell transplantation (ASCT) as part of front-line therapy

Status : Recruiting

Systemic therapy trial

A Phase 2, Open-Label Study of Intratumoral Tavokinogene Telseplasmid Plus...

This phase II trial is evaluating a biological therapy (Tavokinogene Telseplasmid - delivered by electroporation), in combination with an immunotherapy drug (Pembrolizumab), in patients with advanced triple negative breast cancer

Status : Recruiting

Systemic therapy trial

EX-TEM : Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma

This phase III trial is trying to determine if extended post-radiation chemotherapy will improve survival outcomes in patients with newly diagnosed glioblastoma

Status : Recruiting

Systemic therapy trial

A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of...

This phase I trial is evaluating a new intravenous drug (BTRC4017A) in patients with locally advanced or metastatic HER2-expressing cancers

Status : Recruiting

Systemic therapy trial

ICON9 : International Phase III Randomised Study to Evaluate the Efficacy of Maintenance Therapy...

This phase III trial is comparing maintenance therapy with two oral drugs (Olaparib and Cediranib), versus Olaparib as a maintenance therapy alone, in patients with relapsed ovarian cancer

Status : Recruiting

Systemic therapy trial

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of TG-1701, an Irreversible Bruton's...

This phase I trial is evaluating the safety and effectiveness of a new oral drug (TG-1701) for patients with B-cell malignancies that have not responded or gotten worse with prior treatments

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.